Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 6Multiple Myeloma 4Neoplasms, Plasma Cell 2Lymphoma, Follicular 2Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia, Pneumococcal 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia 1Inflammatory Bowel Diseases 1Infections 1Crohn Disease 1Colitis, Ulcerative 1Breast Neoplasms 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 9Ciprofloxacin 7gamma-Globulins 3Voriconazole 3Fluconazole 3Daptomycin 3Antibiotic Prophylaxis 3Amoxicillin-Potassium Clavulanate Combination 3Whole-Body Irradiation 2Vancomycin 2Trimethoprim 2Sulfamethoxazole 2Saline Solution 2Ribavirin 2Peripheral Blood Stem Cell Transplantation 2Pentetic Acid 2Melphalan 2Itraconazole 2Immunoglobulins, Intravenous 2Fosfomycin 2Ethanol 2Cyclophosphamide 2Cefazolin 2Caspofungin 2ziprasidone 1tocilizumab 1telavancin 1telaprevir 1talquetamab 1soybean oil, phospholipid emulsion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Infections × Pneumococcal Vaccines × Clear all
NCT00046852 2019-11-04

Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

University of Maryland, Baltimore

Phase 1/2 Completed
Plasma cell

Infections, Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡